关注
Clemens Wittwehr
Clemens Wittwehr
在 ec.europa.eu 的电子邮件经过验证
标题
引用次数
引用次数
年份
How adverse outcome pathways can aid the development and use of computational prediction models for regulatory toxicology
C Wittwehr, H Aladjov, G Ankley, HJ Byrne, J de Knecht, E Heinzle, ...
Toxicological Sciences 155 (2), 326-336, 2017
1682017
t4 workshop report: pathways of toxicity
A Kleensang, A Maertens, M Rosenberg, S Fitzpatrick, J Lamb, ...
Altex 31 (1), 53, 2014
1092014
Alternative methods for regulatory toxicology–a state-of-the-art review
A Worth, J Barroso, S Bremer, J Burton, S Casati, S Coecke, R Corvi, ...
JRC Sci Policy Rep EUR 26797, 1-475, 2014
682014
Creating a structured adverse outcome pathway knowledgebase via ontology-based annotations
C Ives, I Campia, RL Wang, C Wittwehr, S Edwards
Applied in vitro toxicology 3 (4), 298-311, 2017
612017
EURL ECVAM status report on the development, validation and regulatory acceptance of alternative methods and approaches (2019)
D Asturiol Bofill
Publications Office of the European Union, 2020
522020
Application of AOPs to assist regulatory assessment of chemical risks–Case studies, needs and recommendations
L Bajard, O Adamovsky, K Audouze, K Baken, R Barouki, JB Beltman, ...
Environmental Research 217, 114650, 2023
412023
Artificial Intelligence for chemical risk assessment
C Wittwehr, P Blomstedt, JP Gosling, T Peltola, B Raffael, AN Richarz, ...
Computational Toxicology 13, 100114, 2020
392020
diXa: a data infrastructure for chemical safety assessment
DM Hendrickx, HJWL Aerts, F Caiment, D Clark, TMD Ebbels, CT Evelo, ...
Bioinformatics 31 (9), 1505-1507, 2015
382015
Systematic organization of COVID-19 data supported by the adverse outcome pathway framework
P Nymark, M Sachana, SB Leite, J Sund, CE Krebs, K Sullivan, ...
Frontiers in public health 9, 638605, 2021
312021
Towards a qAOP framework for predictive toxicology-Linking data to decisions
A Paini, I Campia, MTD Cronin, D Asturiol, L Ceriani, TE Exner, W Gao, ...
Computational Toxicology 21, 100195, 2022
212022
Non-animal methods in science and regulation
V ZUANG, A DURA, LE AHS, J BARROSO, LS BATISTA, E BERGGREN, ...
212022
Understanding COVID-19 through adverse outcome pathways–2nd CIAO AOP Design Workshop
C Wittwehr, MJ Amorim, LA Clerbaux, C Krebs, B Landesmann, ...
ALTEX-Alternatives to animal experimentation 38 (2), 351-357, 2021
192021
Alzheimer’s disease, and breast and prostate cancer research: Translational failures and the importance to monitor outputs and impact of funded research
F Pistollato, C Bernasconi, J McCarthy, I Campia, C Desaintes, C Wittwehr, ...
Animals 10 (7), 1194, 2020
182020
The adverse outcome pathway: a conceptual framework to support toxicity testing in the twenty-first century
E Perkins, N Garcia-Reyero, S Edwards, C Wittwehr, D Villeneuve, ...
Computational systems toxicology, 1-26, 2015
172015
COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease–3rd CIAO AOP Design Workshop
LA Clerbaux, N Amigó, MJ Amorim, A Bal-Price, SB Leite, A Beronius, ...
Altex 39 (2), 322–335, 2022
162022
Addressing evidence needs in chemicals policy and regulation
A CARUSI, C WITTWEHR, M WHELAN
122022
Bridging across methods in the biosciences
A CARUSI, M WHELAN, C WITTWEHR
112019
Accelerating progress in the replacement, reduction and refinement of animal testing through better knowledge sharing
T Holley, G Bowe, I Campia, S Belz, E Berggren, A Janusch-Roi, ...
Publications Office of the European Union, 2016
112016
The adverse outcome pathway framework applied to neurological symptoms of COVID-19
HT Hogberg, A Lam, E Ohayon, MA Shahbaz, LA Clerbaux, A Bal-Price, ...
Cells 11 (21), 3411, 2022
102022
OECD harmonised template 201: Structuring and reporting mechanistic information to foster the integration of new approach methodologies for hazard and risk assessment of chemicals
E Carnesecchi, I Langezaal, P Browne, S Batista-Leite, I Campia, ...
Regulatory Toxicology and Pharmacology, 105426, 2023
82023
系统目前无法执行此操作,请稍后再试。
文章 1–20